photo walkheader_zpsd5bunpmi.png

Category Archives: Pancreatic Cancer Stages

Including Grade Status Marker Levels in the Staging of Neuroendocrine Tumors

In a sense, the pancreatic cancer research underlying this blog posting is a bookend to the one that we discussed here in the Pancreatica Blog about a month ago.  Then, researchers had incorporated the Ki-67 cell proliferation marker into a standard Tumor-Node-Metastasis system (American Joint Committee on Cancer – AJCC) to see if the novel […]

Adding Grade Status to Staging Improves Prognostic Capability in Pancreatic Cancer

The pancreatic cancer surgical (and oncology) team at UCLA developed a new experimental staging method such that the tumor’s grade was added to the standard (TNM) AJCC staging criteria, whereby a high-grade tumor increased the pancreatic cancer stage (ductal adenocarcinoma of the pancreas) to the next higher level than would have been otherwise indicated. Published […]

Prolonged Duration of Neoadjuvant Treatment May Confer Big Benefits in Pancreatic Cancer

The move away from surgical diagnosis to radiographic criteria in many and now even most efforts at the staging of pancreatic cancer (ductal adenocarcinoma of the pancreas) carries a number of somewhat unspoken but profound consequences, one being efforts to find ways to downstage the diagnosis so as to profitably utilize surgery in locally advanced […]

Page 1 of 11
Facebook
Facebook